Detalhe da pesquisa
1.
Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study.
Blood
; 140(13): 1470-1481, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35849650
2.
Pharmacokinetics and safety of ticagrelor in infants and toddlers with sickle cell disease aged <24 months.
Pediatr Blood Cancer
; 68(5): e28977, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33629819
3.
Scandcleft Project Trial 2-Comparison of Speech Outcome in 1- and 2-Stage Palatal Closure in 5-Year-Olds With UCLP.
Cleft Palate Craniofac J
; 57(4): 458-469, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31746642
4.
A dose-ranging study of ticagrelor in children aged 3-17 years with sickle cell disease: A 2-part phase 2 study.
Am J Hematol
; 93(12): 1493-1500, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30187935
5.
Inverse Correlation between the Atrial Fibrillatory Rate and the Ventricular Repolarization Time: Observations at Baseline and after an Intravenous Infusion of a Combined Potassium and Sodium Current Blocker.
Ann Noninvasive Electrocardiol
; 21(3): 236-45, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26246430
6.
Is the acetylcholine-regulated inwardly rectifying potassium current a viable antiarrhythmic target? Translational discrepancies of AZD2927 and A7071 in dogs and humans.
Europace
; 17(3): 473-82, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25082948
7.
Rapid slowing of the atrial fibrillatory rate after administration of AZD7009 predicts conversion of atrial fibrillation.
J Electrocardiol
; 47(3): 316-23, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24508473
8.
Assessment of ventricular repolarization variability with the DeltaT50 method improves identification of patients with congenital long QT syndromes.
Ann Noninvasive Electrocardiol
; 18(3): 240-50, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23714082
9.
Decrease of the atrial fibrillatory rate, increased organization of the atrial rhythm and termination of atrial fibrillation by AZD7009.
J Electrocardiol
; 46(1): 29-35, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23219385
10.
Pharmacological cardioversion of atrial fibrillation--a double-blind, randomized, placebo-controlled, multicentre, dose-escalation study of AZD1305 given intravenously.
Europace
; 13(8): 1148-56, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21561900
11.
DeltaT50--a new method to assess temporal ventricular repolarization variability.
J Electrocardiol
; 44(4): 477.e1-9, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21704223
12.
A randomized invasive cardiac electrophysiology study of the combined ion channel blocker AZD1305 in patients after catheter ablation of atrial flutter.
J Cardiovasc Pharmacol
; 56(3): 300-8, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20588189
13.
Prediction of drug-related morphological changes of the T wave.
Scand Cardiovasc J
; 44(4): 215-22, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20429697
14.
Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials.
Lancet Rheumatol
; 2(1): e31-e41, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258274
15.
Rapid conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.
J Clin Pharmacol
; 49(3): 312-22, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19129422
16.
The nasal alar elevator: a new device that may reduce the need for primary operation of the nose in patients with cleft lip.
Scand J Plast Reconstr Surg Hand Surg
; 43(2): 71-4, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19308856
17.
Population Pharmacokinetics/Pharmacodynamics of Ticagrelor in Children with Sickle Cell Disease.
Clin Pharmacokinet
; 58(10): 1295-1307, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972696
18.
Development Strategy and Relative Bioavailability of a Pediatric Tablet Formulation of Ticagrelor.
Clin Drug Investig
; 39(8): 765-773, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31140114
19.
Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3).
Contemp Clin Trials
; 85: 105835, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31446143
20.
Prothrombin time is predictive of low plasma prothrombin concentration and clinical outcome in patients with trauma hemorrhage: analyses of prospective observational cohort studies.
Scand J Trauma Resusc Emerg Med
; 25(1): 30, 2017 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28292321